Immunomodulating Nanomedicine for Cancer Therapy

Zhigang Liu, Wen Jiang, Jutaek Nam, James J. Moon, Betty Y.S. Kim

Research output: Contribution to journalArticle

29 Scopus citations


Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)6655-6659
Number of pages5
JournalNano Letters
Issue number11
StatePublished - Nov 14 2018


  • Nanomedicine
  • cancer immunotherapy
  • cancer vaccine
  • drug delivery
  • nanotechnology

ASJC Scopus subject areas

  • Bioengineering
  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering

Fingerprint Dive into the research topics of 'Immunomodulating Nanomedicine for Cancer Therapy'. Together they form a unique fingerprint.

  • Cite this

    Liu, Z., Jiang, W., Nam, J., Moon, J. J., & Kim, B. Y. S. (2018). Immunomodulating Nanomedicine for Cancer Therapy. Nano Letters, 18(11), 6655-6659.